GLY-200

· Glyscend, Inc.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for GLY-200, covering 2025-01-23 to 2025-02-10. Get the full timeline:

Most recent: Clinical Trial Update: A Study Evaluating the Safety, Tolerability, and Pharmacodynamic Effects of GLY-200 in Type 2 Diabetic Patients [Phase 2]

See pricing